NASDAQ · Drug Manufacturers - Specialty & Generic

Kamada Ltd. (KMDA) Stock

$7.77 +0.52% NASDAQ: KMDA Healthcare

Valuation

MetricValue
Price$7.77
Market Cap$448.28M
P/E Ratio21.70
P/B Ratio1.78
P/S Ratio2.50
EPS (TTM)$0.37
52-Week High$9.35
52-Week Low$6.50
Dividend Yield4.09%

Financials & Margins

MetricValue
ROE8.37%
ROA5.81%
ROCE8.33%
Gross Margin14.36%
Operating Margin14.36%
Net Margin11.60%
Debt/Equity0.04
Current Ratio4.11

Annual Financials (USD)

Metric20212022202320242025
Revenue$104.0M$129.0M$143.0M$161.0M$180.0M
Operating Profit$-1.0M$5.0M$10.0M$20.0M$26.0M
Net Profit$-2.0M$-2.0M$8.0M$14.0M$20.0M
EPS$-0.05$-0.05$0.15$0.25$0.37
Op Margin-0.7%3.5%7.1%12.5%14.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$319.0M$322.0M$355.0M$372.0M$379.0M
Total Liabilities$142.0M$146.0M$111.0M$113.0M$110.0M
Cash$19.0M$34.0M$56.0M$78.0M$75.0M
Borrowings$24.0M$21.0M$9.0M$11.0M$12.0M

Latest News

Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting GlobeNewswire · Jul 13, 2026 Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory GlobeNewswire · Jun 1, 2026 Kamada Ltd (KMDA) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Shipment Delays GuruFocus.com · May 13, 2026 Kamada (KMDA) Q1 2026 Earnings Transcript Motley Fool · May 13, 2026 Kamada Ltd. Q1 2026 Earnings Call Summary Moby · May 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-9.0M$29.0M$4.0M$48.0M$28.0M
Investing Cash Flow$-67.0M$-8.0M$-12.0M$-21.0M$-21.0M
Financing Cash Flow$-1.0M$-6.0M$-17.0M$-13.0M$-6.0M
Net Cash Flow$-52.0M$16.0M$21.0M$23.0M$-3.0M
Free Cash Flow$-13.0M$25.0M$-2.0M$37.0M$17.0M

Valuation & Return Ratios

MetricValue
PEG Ratio1.84
EV / EBITDA11.00
FCF Yield5.52%
Quick Ratio2.29
Interest Coverage26.84
Return 1Y-9.34%
Return 3Y46.94%
Return 5Y36.54%

Ownership

Insiders Held7.20%
Institutions Held48.60%
Institutions Float Held52.36%
Institutional HolderSharesReport Date
Phoenix Financial Ltd.1,654,9522026-03-31
Renaissance Technologies, LLC762,9482026-03-31
Wells Fargo & Company597,2362026-03-31
Acadian Asset Management. LLC371,5582026-03-31
ARK Investment Management, LLC269,5572026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADMAADMA Biologics Inc $10.68 -2.47% 14.08 $2.39B 0.00%
EBSEmergent BioSolutions Inc. $6.23 +0.00% -1.84 $319.43M 0.00%
PHARPharming Group N.V. $9.68 -1.22% 66.30 $685.13M 0.00%

About Kamada Ltd.

Kamada Ltd. is led by CEO Amir London, employs 420 people, headquartered in IL, publicly traded since 2013.

Kamada Ltd. (KMDA) stock trades at $7.77 with a market capitalization of $448.28M. The stock is valued at a price-to-earnings (P/E) ratio of 21.70, price-to-book of 1.78, price-to-sales of 2.50. Over the past 52 weeks the stock has ranged between $6.50 and $9.35, and currently trades 16.9% below its 52-week high. It pays a dividend yielding 4.09%.

On profitability, Kamada Ltd. generates a return on equity (ROE) of 8.37%, return on capital employed of 8.33%, an operating margin of 14.36%, a net profit margin of 11.60%.

Kamada Ltd. by the numbers, 2016–2025

Between 2016 and 2025 Kamada Ltd. reported revenue of $77.0M rising to $180.0M, a change of +133.8% across 10 years. Compounded, revenue has grown 6.2% a year over five years, 11.7% over three, 11.8% over the last twelve months. Net profit rose to $20.0M.

Operating margin went from -7.5% in 2016 to 14.5% in 2025, a gain of 22.1 percentage points. The most recent net margin is 11.60%. On a trailing twelve-month basis to Jun '26, revenue is $192.0M and net profit $22.0M.

Borrowings rose from $2.0M to $12.0M, cash from operations was $28.0M in the latest year, positive in 9 of the last 10.

Return on equity has averaged 2.8% over five years, and was 7.4% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Kamada Ltd. (KMDA) — frequently asked questions

What is Kamada Ltd. (KMDA) stock price today?

Kamada Ltd. (KMDA) is currently trading at $7.77, up 0.52% today.

What is KMDA P/E ratio?

Kamada Ltd.'s P/E ratio is 21.70. This is between 15x and 30x, around the typical market average of roughly 18-22x.

What is KMDA return on equity (ROE)?

Kamada Ltd.'s return on equity (ROE) is 8.37%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.

What is Kamada Ltd.'s market cap?

Kamada Ltd. has a market capitalization of $448.28M.

Does KMDA pay a dividend?

Yes. Kamada Ltd. currently yields 4.09%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does KMDA carry?

Kamada Ltd. has a debt-to-equity ratio of 0.04. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is KMDA's profit margin?

Kamada Ltd. reports a net profit margin of 11.60% — the share of revenue left after every cost, including tax and interest.

What sector is KMDA in?

Kamada Ltd. is classified under Healthcare, in the Drug Manufacturers - Specialty & Generic industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is KMDA listed on?

Kamada Ltd. trades on NASDAQ under the ticker KMDA.

What is KMDA's 52-week range?

Over the last year Kamada Ltd. has traded between $6.50 and $9.35.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens KMDA currently matches

On the figures above, Kamada Ltd. passes the filters for 13 of our ready-made screens, among them Dividend Stocks Under $10, Small Cap Stocks, Stocks Under $10. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Dividend Stocks Under $10Small Cap StocksStocks Under $10Debt Free Stocks Under $100Debt Free StocksStocks Under $100Stocks Under $50Small Cap Dividend StocksDividend Yield Over 3%Stocks With PE Under 25Stocks With PE Under 30Debt to Equity Below 1 StocksHigh Current Ratio Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.